Cover Image

Impact of delisting OTC medicines from reimbursement list

Saved in:

Bibliographic Details
Main Authors:	Petra Chytilová (Author), Robin Šebesta (Author)
Format:	Book
Published:	Taylor & Francis Group, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of the domestic list of otc medicines and development of approaches to its improvement
by: L. O. Hala, et al.
Published: (2022)

Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children
by: E. Petro, et al.
Published: (2024)

Delisting Medical Imaging in Private Settings from Public Coverage in Québec
by: Amélie Quesnel-Vallée
Published: (2013)

Delisting Medical Imaging in Private Settings from Public Coverage in Quebec
by: Amélie Quesnel-Vallée
Published: (2013)

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List
by: Wenbin Liu, et al.
Published: (2019)

Consumer Likelihood to Seek Information on OTC Medicines
by: Jeffrey G. Taylor, et al.
Published: (2023)

Consumer Impressions of the Safety and Effectiveness of OTC Medicines
by: Jeffrey Gordon Taylor, et al.
Published: (2023)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023)

Restoring ornithine transcarbamylase (OTC) activity in an OTC‐deficient mouse model using LUNAR‐OTC mRNA
by: Hailong Yu, et al.
Published: (2022)

Were economic evaluations well reported for the newly listed oncology drugs in China's national reimbursement drug list
by: Liu Liu, et al.
Published: (2022)

The Impact of the Socio-Demographic Characteristics of Complementary and Alternative Medicine Users in Serbia on OTC Drug Consumption
by: Marina Luketina-Sunjka, et al.
Published: (2019)

In-depth analysis of OTC A208T case induced by OTC gene mutation and research on the prediction and simulation of the impact on protein function
by: Qingyang Hu, et al.
Published: (2024)

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016
by: A. S. Kolbin, et al.
Published: (2016)

Over-the -counter medicines (OTC), how to avoid causing health problems?
by: Théophile eGodfraind
Published: (2012)

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study
by: Hong Zhu, et al.
Published: (2022)

Budget impact of publicly reimbursed prescription medicines in The Republic of Srpska
by: Tamara ePetrusic, et al.
Published: (2015)

Stratified Medicine and Reimbursement Issues
by: Hans-Joerg eFugel, et al.
Published: (2012)

Medicines pricing and reimbursement in Canada
by: Chris BONNETT, et al.
Published: (2022)

Purchase of prescription and OTC medicines in Slovakia: factors influencing patients' expectations and satisfaction
by: Zuzana Haramiova, et al.
Published: (2017)

Examining the evolution and impact of OTC vending machines in Global Healthcare Systems
by: Ammar Abdulrahman Jairoun, et al.
Published: (2024)

Antiobesity drugs utilization trend analysis and reimbursement lists status: The perspective of selected European countries
by: Stević Ivana, et al.
Published: (2024)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
by: Tomas Tesar, et al.
Published: (2021)

Medicines Compliance and Reimbursement Level in Portugal
by: Maria da Conceição Constantino Portela, et al.
Published: (2015)

Medicines regulation, pricing and reimbursement in Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Development of a Propensity to Self-Medicate with Over-the-Counter Medicines Scale (PSM-OTC)
by: Oluwasola Ayosanmi, et al.
Published: (2022)

DIPLOMASI EKONOMI INDONESIA DALAM MENYIKAPI DELISTING PRODUKRUMPUT LAUT INDONESIA OLEH US NATIONAL ORGANIC STANDARD BOARD (NOSB)
by: Ketty Rummeinur Kusuma,
Published: (2020)

Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers
by: Yuko Tanibuchi, et al.
Published: (2024)

Potential Rx-to-OTC Switch Drug Candidates
by: Victor Phan, et al.
Published: (2016)

Medicines pricing and reimbursement: innovation, competitiveness, and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Reimbursement process of medicinal products in Poland and in the world
by: Aneta Katarzyna Mela
Published: (2020)

Purchasing Over The Counter (OTC) Medicinal Products Containing Codeine - Easy Access, Advertising, Misuse and Perceptions of Medicinal Risk
by: John SG Wells, et al.
Published: (2018)

Impact of reimbursement program "Аffordable Medicines" on consumptiom of betablockers in Ukraine in 2017-2020
by: Anton Gonchar, et al.
Published: (2022)

The practice of OTC counseling by community pharmacists in Parana, Brazil
by: Halila GC, et al.
Published: (2015)

Italy - a study case of medicines pricing and reimbursement
by: Valdete A. MELO, et al.
Published: (2022)

A systematic review on reporting quality of economic evaluations for negotiated glucose-lowering drugs in China national reimbursement drug list
by: Shi-Yi Bao, et al.
Published: (2024)

Personal Determinants of Young Adults' Willingness to Use OTC Painkillers
by: Izabella Maria Łukasik, et al.
Published: (2022)

Hyperammonemic coma in a patient with late-onset OTC deficiency
by: V. D'Onofrio, et al.
Published: (2014)

The risk-value trade-off: price and brand information impact consumers' intentions to purchase OTC drugs
by: Lisa Aufegger, et al.
Published: (2021)

Retrospective financial analysis of medicines reimbursement services in community pharmacy
by: Elena Chitan
Published: (2015)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
by: Agnes Vitry
Published: (2015)